Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.
出版信息
Can Urol Assoc J. 2008 Jun;2(3):175-82.
Abstract
摘要
相似文献
1
Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.
Can Urol Assoc J. 2008 Jun;2(3):175-82.
2
Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.
Can Urol Assoc J. 2013 Jul-Aug;7(7-8):238-43. doi: 10.5489/cuaj.536.
3
Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.
Can Urol Assoc J. 2015 May-Jun;9(5-6):164-70. doi: 10.5489/cuaj.2894.
4
Management of kidney cancer: canadian kidney cancer forum consensus update 2011.
Can Urol Assoc J. 2012 Feb;6(1):16-22. doi: 10.5489/cuaj.11273.
5
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769.
6
Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.
Can Urol Assoc J. 2014 May;8(5-6):E398-412. doi: 10.5489/cuaj.1894.
7
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Can Urol Assoc J. 2020 Apr;14(4):E137-E149. doi: 10.5489/cuaj.6082. Epub 2019 Nov 5.
8
Canadian Forum on Combined Organ Transplantation.
Transplantation. 2016 Jun;100(6):1339-48. doi: 10.1097/TP.0000000000000963.
9
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.
Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362.
10
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.
J Vet Intern Med. 2018 Nov;32(6):1803-1822. doi: 10.1111/jvim.15331. Epub 2018 Oct 24.
引用本文的文献
1
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.
Can Urol Assoc J. 2021 Apr;15(4):84-97. doi: 10.5489/cuaj.7245.
2
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.
Can Urol Assoc J. 2019 Oct;13(10):343-354. doi: 10.5489/cuaj.6256.
3
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769.
4
Initial Experience of Sorafenib Neoadjuvant Therapy Combined with Retroperitoneoscopy in Treating T2 Large Renal Carcinoma.
Biomed Res Int. 2015;2015:609549. doi: 10.1155/2015/609549. Epub 2015 Sep 3.
5
Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.
Can Urol Assoc J. 2015 May-Jun;9(5-6):164-70. doi: 10.5489/cuaj.2894.
6
Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.
Can Urol Assoc J. 2013 Jul-Aug;7(7-8):238-43. doi: 10.5489/cuaj.536.
7
Management of kidney cancer: canadian kidney cancer forum consensus update 2011.
Can Urol Assoc J. 2012 Feb;6(1):16-22. doi: 10.5489/cuaj.11273.
8
Recent developments in kidney cancer.
Can Urol Assoc J. 2011 Jun;5(3):195-203. doi: 10.5489/cuaj.10148.
9
Treatment of metastatic renal cell carcinoma.
Nat Rev Urol. 2010 Jun;7(6):327-38. doi: 10.1038/nrurol.2010.57. Epub 2010 May 11.
10
[Not Available].
Can Urol Assoc J. 2009 Jun;3(3):200-204. doi: 10.5489/cuaj.1069.
本文引用的文献
1
Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma.
Can Urol Assoc J. 2009 Feb;3(1):73-6. doi: 10.5489/cuaj.1028.
2
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
J Urol. 2008 Jan;179(1):81-6; discussion 86. doi: 10.1016/j.juro.2007.08.127. Epub 2007 Nov 12.
3
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.
Cancer. 2007 Dec 1;110(11):2468-77. doi: 10.1002/cncr.23056.
4
Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy.
J Urol. 2007 Aug;178(2):379-86. doi: 10.1016/j.juro.2007.03.131. Epub 2007 Jun 11.
5
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
N Engl J Med. 2007 May 31;356(22):2271-81. doi: 10.1056/NEJMoa066838.
6
Sorafenib in advanced clear-cell renal-cell carcinoma.
N Engl J Med. 2007 Jan 11;356(2):125-34. doi: 10.1056/NEJMoa060655.
7
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044.
8
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.
Lancet Oncol. 2006 Sep;7(9):735-40. doi: 10.1016/S1470-2045(06)70803-8.
9
Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.
AJR Am J Roentgenol. 2005 Jul;185(1):72-80. doi: 10.2214/ajr.185.1.01850072.
10
Renal cryoablation: outcome at 3 years.
J Urol. 2005 Jun;173(6):1903-7. doi: 10.1097/01.ju.0000158154.28845.c9.
Zotero 插件